In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
about
CRISPR-Cas Genome Surgery in Ophthalmology.CRISPR Editing Technology in Biological and Biomedical Investigation.CRISPR-Cas orthologues and variants: optimizing the repertoire, specificity and delivery of genome engineering tools.A Broad-Spectrum Inhibitor of CRISPR-Cas9.Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism.Progress and Prospects of CRISPR/Cas Systems in Insects and Other Arthropods.Immunity to CRISPR Cas9 and Cas12a therapeutics.A Single-Chain Photoswitchable CRISPR-Cas9 Architecture for Light-Inducible Gene Editing and Transcription.In vivo genome editing improves motor function and extends survival in a mouse model of ALS.In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells.Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell-Free Transcription-Translation System.Current status and perspectives of genome editing technology for microalgae.Efficient Generation of Genome-Modified Mice Using Campylobacter jejuni-Derived CRISPR/Cas.Type II-C CRISPR-Cas9 Biology, Mechanism, and Application.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.High-Throughput Approaches to Pinpoint Function within the Noncoding Genome.RNA-dependent RNA targeting by CRISPR-Cas9.Genetically engineered pigs as models for human disease.In vivo genome editing thrives with diversified CRISPR technologies.Genome Surgery and Gene Therapy in Retinal Disorders.The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.Applications of CRISPR/Cas9 in the Mammalian Central Nervous System.CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9.Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.Peptide/Cas9 nanostructures for ribonucleoprotein cell membrane transport and gene edition.CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration.Gene therapy and genome surgery in the retina.Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.Systematic evaluation of CRISPR-Cas systems reveals design principles for genome editing in human cells.The CRISPR tool kit for genome editing and beyond.In Vivo Applications of CRISPR-Based Genome Editing in the Retina.CRISPR/Cas9 genome surgery for retinal diseasesAll-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivoMinimal PAM specificity of a highly similar SpCas9 orthologIn Vivo Genome Editing as a Therapeutic ApproachInhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3'-overhang
P2860
Q33745403-4BCAB80F-69C4-4932-B4BE-163FEE99785CQ38688945-20C7BCD2-C093-4D79-B528-3C360545412DQ38716317-E01902B7-04F7-4254-AB87-C320017741C9Q40068953-0583EBE9-D8B2-4D81-8943-BFCAA05CF3A6Q40120224-CC3DFB9D-28E2-4742-8785-2012DF066EFEQ41430829-56A64376-67CE-4A6D-B609-6B5E91438B5DQ45873745-7AB815A6-8F7F-4835-A78B-1BEFA3125988Q45981156-A2AECAC3-CC95-4AD0-88F2-549BF4845823Q47153099-D8935E49-633E-4D70-9787-4C892877392DQ47161048-362391BF-7FAB-4AEC-8AF5-C90499DBD99EQ47162699-B0385467-8C07-4647-80A2-7812B31E93ACQ47198422-7E656BB4-64FD-4037-8676-862F4F3AC24CQ47226763-DC073D41-B15C-48F9-AD78-1EE06C0DC0EBQ47240267-988FE530-1173-4FB7-ACCF-831590A0BB46Q47334186-D91AD51F-5299-4B56-8AAE-557BE5646264Q47553772-8B5B7D27-C623-4C77-8EC2-851BE8113ED3Q47594697-A2F8367B-E97C-4966-8FE8-5D9C921A06DFQ48304493-C6DA75CA-FF49-4AC4-A0F8-10300BBC3993Q50107614-EA8333CA-E845-4D31-8CEA-33932D42B942Q52363995-599D9EF6-B516-48F0-8A23-08A7129DA178Q52429662-1ED0E179-4594-472E-9B9D-8674B6E70CF3Q52429663-064D82F3-84A8-49B8-BE75-62F09645D66EQ52429670-C884BBB6-5749-4D36-A06F-65FEE0B78870Q52430557-F70EC0C9-E5B7-4CD3-9C82-7AA9B1AF8755Q52430644-C08AA157-D9EE-4F77-8AE1-B0B3FCF64D32Q52430861-8B26FEBA-FC99-4BB8-9B8B-87AEB29BFC03Q52431312-236805DB-AC52-4BE2-93E3-105202E6D580Q54941286-478AA003-A73C-48C0-BDCD-0D9C8D6317AEQ54977409-1E34DA97-28D0-4752-A56D-37A02B0A18AEQ55000684-A4FC536E-8309-4752-8519-09A3FCE5A61BQ55069666-D24EFC67-B424-4A19-A5B7-F4A75A3BDC4EQ55233775-DB13C4A9-AF9E-4F24-AF6A-9DCF6B0BB858Q55262727-95C808E6-6016-4441-BFDA-F4DCCF6A6709Q57171979-AE8B962A-8860-48DE-B179-4F7AE36FD917Q58324031-0E3BBB8F-802B-49EF-9258-C93C18DC4EE4Q58569539-0C33C7F1-33A4-4BC6-A05D-48C5A231A5D5Q58745391-F25389E2-E965-4B02-BD6B-A4E311265361Q58750557-2BE2E70E-2122-4C9B-AB02-A9A20AABD690Q58759613-9CDB7E4B-3D26-4AC5-AA1C-028D04B05640
P2860
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
@ast
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
@en
type
label
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
@ast
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
@en
prefLabel
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
@ast
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
@en
P2093
P2860
P356
P1476
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
@en
P2093
Daesik Kim
Dong Woo Song
Hee-Yeon Cho
Jeong Hun Kim
Jin Hyoung Kim
Kyoungmi Kim
Kyu Jun Lee
Min Hee Jung
Seokjoong Kim
P2860
P2888
P356
10.1038/NCOMMS14500
P407
P50
P577
2017-02-21T00:00:00Z
P6179
1083852488